Article
[Cancer immunotherapy--current status].
Therapeutische Umschau. Revue therapeutique - 1 Apr 2006
Kundig T M, Renner Ch, Knuth A
Abstract excerpt
Cancer immunotherapy includes passive and active strategies. Passive immunotherapy such as the use of therapeutic monoclonal antibodies, and in a broader sense also of other immunological effector molecules, such as interferon-alpha is clinically established. The efficacy of passive immunotherapy attests to the fact that the immune system can successfully fight cancer. The logical next step is therefore to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
